An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 202067
Company: LUNDBECK PHARMS LLC

Medication Guide

Products on NDA 202067

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ONFI	CLOBAZAM	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET;ORAL	Discontinued	None	Yes	No
ONFI	CLOBAZAM	10MG	TABLET;ORAL	Prescription	AB	Yes	No
ONFI	CLOBAZAM	20MG	TABLET;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 202067

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/21/2011	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD; Orphan	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202067s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202067s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202067Orig1s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/12/2024	SUPPL-8	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202067s008,203993s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/202067Orig1s008, 203993Orig1s010ltr.pdf
01/13/2023	SUPPL-7	Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/202067Orig1s007;203993Orig1s009ltr.pdf
02/05/2021	SUPPL-6	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202067s006,203993s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/202067Orig1s006; 203993Orig1s008ltr.pdf
06/15/2018	SUPPL-5	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202067s005,203993s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/202067Orig1s005,203993Orig1s007ltr.pdf
12/16/2016	SUPPL-4	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202067s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/202067Orig1s004,203993Orig1s005ltr.pdf
12/09/2014	SUPPL-3	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202067s003,203993s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202067Orig1s003,203993Orig1s003ltr.pdf
11/21/2013	SUPPL-2	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202067s002,203993s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/202067Orig1s002,203993Orig1s002ltr.pdf
03/01/2013	SUPPL-1	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202067s001lbl.pdf

Labels for NDA 202067

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/12/2024	SUPPL-8	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202067s008,203993s010lbl.pdf
03/12/2024	SUPPL-8	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202067s008,203993s010lbl.pdf
01/13/2023	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf
01/13/2023	SUPPL-7	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf
02/05/2021	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202067s006,203993s008lbl.pdf
06/15/2018	SUPPL-5	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202067s005,203993s007lbl.pdf
12/16/2016	SUPPL-4	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202067s004lbl.pdf
12/09/2014	SUPPL-3	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202067s003,203993s003lbl.pdf
12/09/2014	SUPPL-3	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202067s003,203993s003lbl.pdf
11/21/2013	SUPPL-2	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202067s002,203993s002lbl.pdf
03/01/2013	SUPPL-1	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202067s001lbl.pdf
10/21/2011	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202067s000lbl.pdf

Therapeutic Equivalents for NDA 202067

ONFI

TABLET;ORAL; 10MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	212714	ALKEM LABS LTD
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	209718	AMNEAL PHARMS CO
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	208825	BIONPHARMA
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	209308	BRECKENRIDGE
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	209795	HETERO LABS LTD III
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	210545	LUPIN LTD
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	211711	MICRO LABS
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	213404	MSN
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	209808	PIRAMAL HLTHCARE UK
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	209687	UPSHER SMITH LABS
CLOBAZAM	CLOBAZAM	10MG	TABLET;ORAL	Prescription	No	AB	211449	ZYDUS PHARMS
ONFI	CLOBAZAM	10MG	TABLET;ORAL	Prescription	Yes	AB	202067	LUNDBECK PHARMS LLC

TABLET;ORAL; 20MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	212714	ALKEM LABS LTD
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	209718	AMNEAL PHARMS CO
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	208825	BIONPHARMA
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	209795	HETERO LABS LTD III
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	210545	LUPIN LTD
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	211711	MICRO LABS
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	213404	MSN
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	209808	PIRAMAL HLTHCARE UK
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	209687	UPSHER SMITH LABS
CLOBAZAM	CLOBAZAM	20MG	TABLET;ORAL	Prescription	No	AB	211449	ZYDUS PHARMS
ONFI	CLOBAZAM	20MG	TABLET;ORAL	Prescription	Yes	AB	202067	LUNDBECK PHARMS LLC

Top